Tonya Grider, APRN
Primary Care · Manhattan, KSNPI 1477298818
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations.
Across 25 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$91
- Kiniksa Pharmaceuticals International, PLC$66
- E.r. Squibb & Sons, L.L.C.$49
- AbbVie$49
- Boehringer Ingelheim$43
- AstraZeneca$35
- plus $170 from 8 others
What the payments were for
- Food & beverage$47996%
- Education$234%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 5 | $91 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $49 |
| AbbVie | 3 | $49 |
| Boehringer Ingelheim | 2 | $43 |
| AstraZeneca | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Sanofi | 1 | $24 |
| Medtronic | 1 | $23 |
| Lantheus Medical Imaging, Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $19 |
| Reflow Medical Inc | 1 | $18 |
| Novo Nordisk | 1 | $14 |
How this compares
$502 in reported general payments places this provider in the 65th percentile of 56 primary care providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 15 | $10,143 |
| Metoprolol Succinate | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other primary care in Manhattan
- Kelsey EllisManhattan$79
- Michelle PragerTopeka$39K
- Kerry SanderStilwell$9K
- Kristina GroveOverland Park$9K
- Amy BakerLawrence$7K
- Thuy NguyenJetmore$4K
- Debra LyneSalina$4K
- Phuong DuongWichita$3K
- Danielle CarmitchelOverland Park$2K
- Erika DickChanute$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.